TY - JOUR AU - Bollag, D. M. AU - McQueney, P. A. AU - Zhu, J. PY - 1995 DA - 1995// TI - Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action JO - Cancer Res VL - 55 ID - Bollag1995 ER - TY - JOUR AU - Giannakakou, P. AU - Gussio, R. AU - Nogales, E. PY - 2000 DA - 2000// TI - A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.040546297 DO - 10.1073/pnas.040546297 ID - Giannakakou2000 ER - TY - JOUR AU - Fumoleau, P. AU - Coudert, B. AU - Isambert, N. PY - 2007 DA - 2007// TI - Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues JO - Ann Oncol VL - 18 UR - https://doi.org/10.1093/annonc/mdm173 DO - 10.1093/annonc/mdm173 ID - Fumoleau2007 ER - TY - JOUR AU - Thomas, E. S. AU - Gomez, H. L. AU - Li, R. K. PY - 2007 DA - 2007// TI - Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.12.6557 DO - 10.1200/JCO.2007.12.6557 ID - Thomas2007 ER - TY - STD TI - Bristol-Myers Squibb: Ixempra® Prescribing Information. 3/2009 update. www.accessdata.fda.gov/drugsatfda_docs/label/2007/022065lbl.pdf (date last Accessed: 1 June 2016) UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022065lbl.pdf ID - ref5 ER - TY - JOUR AU - Zhang, P. AU - Sun, M. AU - Qiu, R. PY - 2011 DA - 2011// TI - Phase I clinical and pharmacokinetic study of UTD1, a genetically engineered epothilone analog in patients with advanced solid tumors JO - Cancer Chemother Pharmacol VL - 68 UR - https://doi.org/10.1007/s00280-011-1571-6 DO - 10.1007/s00280-011-1571-6 ID - Zhang2011 ER - TY - JOUR AU - Brogdon, C. F. AU - Lee, F. Y. AU - Canetta, R. M. PY - 2014 DA - 2014// TI - Development of other microtubule-stabilizer families: the epothilones and their derivatives JO - Anticancer Drugs VL - 25 UR - https://doi.org/10.1097/CAD.0000000000000071 DO - 10.1097/CAD.0000000000000071 ID - Brogdon2014 ER - TY - JOUR AU - Ferrandina, G. AU - Mariani, M. AU - Andreoli, M. PY - 2012 DA - 2012// TI - Novel drugs targeting microtubules: the role of epothilones JO - Curr Pharm Des VL - 18 UR - https://doi.org/10.2174/138161212800626238 DO - 10.2174/138161212800626238 ID - Ferrandina2012 ER - TY - JOUR AU - Jassem, J. AU - Fein, L. AU - Karwal, M. PY - 2012 DA - 2012// TI - Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies JO - Breast VL - 21 UR - https://doi.org/10.1016/j.breast.2011.09.003 DO - 10.1016/j.breast.2011.09.003 ID - Jassem2012 ER - TY - JOUR AU - Perez, E. A. AU - Lerzo, G. AU - Pivot, X. PY - 2007 DA - 2007// TI - Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.3849 DO - 10.1200/JCO.2006.09.3849 ID - Perez2007 ER - TY - JOUR AU - Low, J. A. AU - Wedam, S. B. AU - Lee, J. J. PY - 2005 DA - 2005// TI - Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.10.024 DO - 10.1200/JCO.2005.10.024 ID - Low2005 ER - TY - JOUR AU - Sparano, J. A. AU - Vrdoljak, E. AU - Rixe, O. AU - Xu, B. AU - Manikhas, A. AU - Medina, C. AU - Crocamo, S. AU - Costa, V. D. AU - Ro, J. AU - Rubio, G. AU - Rondinon, M. AU - Manga, G. P. AU - Peck, R. AU - Poulart, V. AU - Conte, P. PY - 2010 DA - 2010// TI - Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.24.4244 DO - 10.1200/JCO.2009.24.4244 ID - Sparano2010 ER - TY - JOUR AU - Thomas, E. AU - Tabernero, J. AU - Fornier, M. PY - 2007 DA - 2007// TI - Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.9102 DO - 10.1200/JCO.2006.08.9102 ID - Thomas2007 ER - TY - JOUR AU - Nobili, S. AU - Landini, I. AU - Mazzei, T. AU - Mini, E. PY - 2012 DA - 2012// TI - Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression JO - Med Res Rev VL - 32 UR - https://doi.org/10.1002/med.20239 DO - 10.1002/med.20239 ID - Nobili2012 ER - TY - JOUR AU - Shen, H. AU - Lee, F. Y. AU - Gan, J. PY - 2011 DA - 2011// TI - Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2) JO - J Pharmacol Exp Ther VL - 337 UR - https://doi.org/10.1124/jpet.110.175604 DO - 10.1124/jpet.110.175604 ID - Shen2011 ER - TY - JOUR AU - Bijman, M. N. A. AU - Nieuw Amerongen, G. P. AU - Laurens, N. AU - Hinsbergh, V. W. M. AU - Boven, E. PY - 2006 DA - 2006// TI - Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-06-0242 DO - 10.1158/1535-7163.MCT-06-0242 ID - Bijman2006 ER - TY - STD TI - Kok JW, Klappe K, Hummel I. The role of the actin cytoskeleton and lipid rafts in the localization and function of the ABCC1 transporter. Adv Biol. 2014;3:1-11. ID - ref17 ER - TY - JOUR AU - Smith, A. AU - Roda, D. AU - Yap, T. PY - 2014 DA - 2014// TI - Strategies for modern biomarker and drug development in oncology JO - J Hematol Oncol VL - 7 UR - https://doi.org/10.1186/s13045-014-0070-8 DO - 10.1186/s13045-014-0070-8 ID - Smith2014 ER - TY - JOUR AU - Stellrecht, C. M. AU - Vangapandu, H. V. AU - Le, X. -. F. AU - Mao, W. AU - Shentu, S. PY - 2014 DA - 2014// TI - ATP directed agent, 8-chloro-adenosine, induces AMP activated protein kinase activity, leading to autophagic cell death in breast cancer cells JO - J Hematol Oncol VL - 7 UR - https://doi.org/10.1186/1756-8722-7-23 DO - 10.1186/1756-8722-7-23 ID - Stellrecht2014 ER - TY - JOUR AU - Peereboom, D. M. AU - Murpgy, C. AU - Ahluwalia, M. S. PY - 2014 DA - 2014// TI - Phase II trial of patupilone in patients with brain metastases from breast cancer JO - Neuro Oncol VL - 16 UR - https://doi.org/10.1093/neuonc/not305 DO - 10.1093/neuonc/not305 ID - Peereboom2014 ER -